How safe and effective is oral analgesia for hip fracture patients? – a prospective cohort study by Zehra Abdul Muhammad, Tashfeen Ahmad

Subjects: “…Adverse drug events…”
Get full text

Reducing prescribing cascades by Aaron M. Tejani, Thomas L. Perry

Subjects: Get full text

KNOWLEDGE, ATTITUDE AND PRACTICE AMONG HEALTHCARE PROFESSIONALS TOWARDS ADR REPORTING IN ABBOTTABAD PAKISTAN

Subjects: “…Adverse drug events…”
Get full text

ICD-10 Codes to Identify Adverse Drug Events Associated with Antibiotics in Administrative Data by Hannah Lishman, Amber Cragg, Erica Chuang, Carl Zou, Fawziah Marra, Jennifer Grant, David M. Patrick, Corinne M. Hohl

Subjects: Get full text

Risk assessment of the top 50 drugs associated with drug-induced orthostatic hypotension: a disproportionality analysis of the FAERS and JADER databases by Gaocan Ren, Xiansu Chi, Pingping Huang, Jinhui Zhang, Yanqiu Ding, Lijun Guo, Qinghua Shang, Xiaochang Ma

Subjects: Get full text

Lived experiences of persons on tuberculosis treatment in Nairobi County, Kenya: a mixed methods study by Joan Ondiro, Faith Onyangore, Reagan Onyango, Lenah Muema, Dickens S. Omondi Aduda

Subjects: Get full text

The novel ciprofol versus propofol during gastroenteroscopy in Chinese patients: a meta-analysis by Xiaoyan Liang, Qing Feng, Guozhen Li, Tong Liu, Lingyuan Zeng, Yang Xiao, Kun Zhang

Subjects: Get full text

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease by Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL

Subjects: Get full text

Drug‐Related Hypertension: A Disproportionality Analysis Leveraging the FDA Adverse Event Reporting System by Hao Zhu, Linwei Pan, Hannah Lui, Jing Zhang

Subjects: “…adverse drug events…”
Get full text

Identifying Predictors of Serious Adverse Events in Antidepressant Treatment from a Decade-Long Nationwide Pharmacovigilance Study: Impact of Dementia and Parkinson’s Disease Treat... by Jungmin Han, Minsung Kim, Yujin Kim, Soo Hyeon Lee, Sooyoung Shin, Yeo Jin Choi

Subjects: “…adverse drug events…”
Get full text

Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study by Jingkai Di, Jingkai Di, Jingkai Di, Nan Yang, Nan Yang, Yicong Zhao, Yicong Zhao, Shuai Chen, Zijian Guo, Dongdong He, Chuan Xiang, Chuan Xiang

Subjects: Get full text

Potential adverse events of fluoxetine: a real-world study based on the FAERS database by Xuezheng Gao, Xiangjun Zhou, Zhiqiang Du, Qin Zhou, Ying Jiang, Haohao Zhu

Subjects: Get full text

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese... by Tao Wang, Zhiwei Cui, Yingyong Ou, Siyu Lou, Huayou Chen, Chengyu Zhu, Linmei Zhou, Fan Zou

Subjects: Get full text

Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024) by Yang Yang, Zhiwei Cui, Xiaoshan Feng, Fan Zou, Xiaoling Wu

Subjects: Get full text

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database by Xi-Feng Wang, Lu-Ri Bao, Ta-La Hu, Rui-Feng Xu, Wu-Niri Gao, Jing-Yuan Wang, Jian-Rong Zhao, Zhen-Li Fu, Shu-Fang Wang, Yan Meng

Subjects: Get full text

Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases by Luo Lv, Xiangyang Wu, Yubo Ren, Yuli Guo, Haixiong Wang, Xiaofang Li

Subjects: Get full text

Prevalence and factors associated with preventable drug-related emergency department visits (DRED p ) in elderly patients by Parinya Phoemlap, Somratai Vadcharavivad, Khrongwong Musikatavorn, Nutthada Areepium

Subjects: Get full text

Safety assessment of proteasome inhibitors real world adverse event analysis from the FAERS database by Jinlong Huang, Miaomiao Zhang, Jingyang Lin, Xiuli Yang, Ping Huang, Xiaochun Zheng

Subjects: Get full text

Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the U.S. FDA adverse event reporting system by Chengyu Zhu, Zhiwei Cui, Tingting Liu, Siyu Lou, Linmei Zhou, Junyou Chen, Ruizhen Zhao, Li Wang, Yingyong Ou, Fan Zou

Subjects: Get full text

A refined set of RxNorm drug names for enhancing unstructured data analysis in drug safety surveillance by Wenjing Guo, Fan Dong, Jie Liu, Aasma Aslam, Tucker A. Patterson, Huixiao Hong

Subjects: “…adverse drug events…”
Get full text